Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy

American Journal of Cardiology

Volumn 116, Issue 5, 2015, Pages 757-764

  Maron, Barry J ^a   Casey, Susan A ^a   Chan, Raymond H ^b   Garberich, Ross F ^a   Rowin, Ethan J ^c   Maron, Martin S ^c  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; EUROPEAN SOCIETY OF CARDIOLOGY SUDDEN DEATH RISK MODEL; FEMALE; HEART VENTRICLE FIBRILLATION; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUDDEN DEATH; TACHYCARDIA; AGED; ARRHYTHMIAS, CARDIAC; CARDIOLOGY; CARDIOMYOPATHY, HYPERTROPHIC; CLINICAL TRIAL; COMPLICATION; DEATH, SUDDEN, CARDIAC; EUROPE; FOLLOW UP; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAL SOCIETY; MORTALITY; MULTICENTER STUDY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TIME; TRENDS;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; CARDIOLOGY; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SOCIETIES, MEDICAL; SURVIVAL RATE; TIME FACTORS;

EID: 84952874929     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.05.047     Document Type: Article

References (43)

1. B.J. Maron, S.R. Ommen, C. Semsarian, P. Spirito, I. Olivotto, and M.S. Maron Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine J Am Coll Cardiol 64 2014 83 99
2. B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2013 242 255
3. B.J. Maron Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy Circulation 121 2010 445 456
4. B.J. Maron, J.J. Doerer, T.S. Haas, D.M. Tierney, and F.O. Mueller Sudden deaths in young competitive athletes: analysis of 1866 deaths in the U.S., 1980-2006 Circulation 119 2009 1085 1092
5. P. Spirito, C. Autore, C. Rapezzi, P. Bernabo, R. Badagliacca, M.S. Maron, S. Bongioanni, F. Coccolo, N.A. Estes, C.S. Barilla, E. Biagini, G. Quarta, M.R. Conte, P. Bruzzi, and B.J. Maron Syncope and risk of sudden death in hypertrophic cardiomyopathy Circulation 119 2009 1703 1710
6. M.J. Kofflard, F.J. Ten Cate, C. van der Lee, and R.T. van Domburg Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration J Am Coll Cardiol 41 2003 987 993
7. J.M. Bos, B.J. Maron, M.J. Ackerman, T.S. Haas, P. Sorajja, R.A. Nishimura, B.J. Gersh, and S.R. Ommen Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy Am J Cardiol 106 2010 1481 1486
8. P.M. Elliott, J. Poloniecki, S. Dickie, S. Sharma, L. Monserrat, A. Varnava, N.G. Mahon, and W.J. McKenna Sudden death in hypertrophic cardiomyopathy: identification of high risk patients J Am Coll Cardiol 36 2000 2212 2218
9. B.J. Maron, and E. Braunwald Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease Circulation 126 2012 1640 1644
10. B.J. Maron, W.K. Shen, M.S. Link, A.E. Epstein, A.K. Almquist, J.P. Daubert, G.H. Bardy, S. Favale, R.F. Rea, G. Boriani, N.A. Estes 3rd, and P. Spirito Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N Engl J Med 342 2000 365 373
11. B.J. Maron, P. Spirito, W.K. Shen, T.S. Haas, F. Formisano, M.S. Link, A.E. Epstein, A.K. Almquist, J.P. Daubert, T. Lawrenz, G. Boriani, N.A. Estes 3rd, S. Favale, M. Piccininno, S.L. Winters, M. Santini, S. Betocchi, F. Arribas, M.V. Sherrid, G. Buja, C. Semsarian, and P. Bruzzi Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412
12. C.J. McLeod, S.R. Ommen, M.J. Ackerman, P.L. Weivoda, W.K. Shen, J.A. Dearani, H.V. Schaff, A.J. Tajik, and B.J. Gersh Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy Eur Heart J 28 2007 2583 2588
13. B.J. Maron, P. Spirito, M.J. Ackerman, S.A. Casey, C. Semsarian, N.A. Estes 3rd, K.M. Shannon, E.A. Ashley, S.M. Day, G. Pacileo, F. Formisano, E. Devoto, A. Anastasakis, J.M. Bos, A. Woo, C. Autore, R.H. Pass, G. Boriani, R.F. Garberich, A.K. Almquist, M.W. Russell, L. Boni, S. Berger, M.S. Maron, and M.S. Link Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy J Am Coll Cardiol 61 2013 1527 1535
14. A.F. Schinkel, P.A. Vriesendorp, E.J. Sijbrands, L.J. Jordaens, F.J. Ten Cate, and M. Michels Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis Circ Heart Fail 5 2012 552 559
15. P.A. Vriesendorp, A.F. Schinkel, J. Van Cleemput, R. Willems, L.J. Jordaens, D.A. Theuns, M.A. van Siegtenhorst, T.J. de Ravel, F.J. Ten Cate, and M. Michels Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications Am Heart J 166 2013 496 502
16. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, C.E. Seidman, P.M. Shah, W.H. Spencer, P. Spirito, F.J. Ten Cate, and E.D. Wigle American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy J Am Coll Cardiol 42 2003 1687 1713 Eur Heart J 2003;24:1965-1991
17. B.J. Gersh, B.J. Maron, R.O. Bonow, J.A. Dearani, M.A. Fifer, M.S. Link, S.S. Naidu, R.A. Nishimura, S.R. Ommen, H. Rakowski, C.E. Seidman, J.A. Towbin, J.E. Udelson, and C.W. Yancy 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 124 2011 2761 2796 J Am Coll Cardiol 2011;58:e212-e260
18. C. O'Mahony, M. Tome-Esteban, P.D. Lambiase, A. Pantazis, S. Dickie, W.J. McKenna, and P.M. Elliott A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy Heart 99 2013 534 541
19. P.M. Elliott, A. Anastasakis, M.A. Borger, M. Borggrefe, F. Cecchi, P. Charron, A.A. Hagege, A. Lafont, G. Limongelli, H. Mahrholdt, W.J. McKenna, J. Mogensen, P. Nihoyannopoulos, S. Nistri, P.G. Pieper, B. Pieske, C. Rapezzi, F.H. Rutten, C. Tillmanns, and H. Watkins 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy Eur Heart J 35 2014 2733 2779
20. C. O'Mahony, F. Jichi, M. Pavlou, L. Monserrat, A. Anastasakis, C. Rapezzi, E. Biagini, J.R. Gimeno, G. Limongelli, W.J. McKenna, R.Z. Omar, P.M. Elliott Hypertrophic Cardiomyopathy Outcomes Investigators A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HC risk-SCD) Eur Heart J 35 2014 2010 2020
21. J.J. Goldberger, M.E. Cain, S.H. Hohnloser, A.H. Kadish, B.P. Knight, M.S. Lauer, B.J. Maron, R.L. Page, R.S. Passman, D. Siscovick, W.G. Stevenson, and D.P. Zipes American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death Heart Rhythm 5 2008 e1 e21
22. D.P. Zipes, A.J. Camm, M. Borggrefe, A.E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A.J. Moss, R.J. Myerburg, S.G. Priori, M.A. Quinones, D.M. Roden, M.J. Silka, C. Tracy, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, E.M. Antman, J.L. Anderson, S.A. Hunt, J.L. Halperin, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, S.G. Priori, J.J. Blanc, A. Budaj, A.J. Camm, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Tamargo, and J.L. Zamorano ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death J Am Coll Cardiol 48 2006 e247 346 Circulation 2006;114:e385-e484
23. B.J. Maron, E.J. Rowin, S.A. Casey, T.S. Haas, R.H. Chan, J.E. Udelson, R.F. Garberich, J.R. Lesser, E. Appelbaum, W.J. Manning, and M.S. Maron Risk stratification and outcome of patients with hypertrophic cardiomyopathy over 60 years of age Circulation 127 2013 585 593
24. R.G. Hauser, and B.J. Maron Lessons from the failure and recall of an implantable cardioverter defibrillator Circulation 112 2005 2040 2042
25. P. Spirito, P. Bellone, K.M. Harris, P. Bernabo, P. Bruzzi, and B.J. Maron Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy N Engl J Med 342 2000 1778 1785
26. B.J. Maron, M.S. Maron, and C. Semsarian Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives J Am Coll Cardiol 60 2012 705 715
27. R.H. Chan, B.J. Maron, I. Olivotto, M.J. Pencina, G.E. Assenza, T. Haas, J.R. Lesser, C. Gruner, A.M. Crean, H. Rakowski, J.E. Udelson, E. Rowin, M. Lombardi, F. Cecchi, B. Tomberli, P. Spirito, F. Formisano, E. Biagini, C. Rapezzi, C.N. De Cecco, C. Autore, E.F. Cook, S.N. Hong, C.M. Gibson, W.J. Manning, E. Appelbaum, and M.S. Maron Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy Circulation 130 2014 484 495
28. B.J. Maron, E.J. Rowin, S.A. Casey, M.S. Link, J.R. Lesser, R.H. Chan, R.F. Garberich, J.E. Udelson, and M.S. Maron Hypertrophic cardiomyopathy associated with low cardiovascular mortality with contemporary management strategies J Am Coll Cardiol 65 2015 1915 1928
29. Maron MS, Maron BJ. Clinical impact of contemporary cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy. Circulation. In press.
30. R. O'Hanlon, A. Grasso, M. Roughton, J.C. Moon, S. Clark, R. Wage, J. Webb, M. Kulkami, D. Dawson, L. Sulaibeekh, B. Chandrasekaran, C. Bucciarelli-Ducci, F. Pasquale, M.R. Cowie, W.J. McKenna, M.N. Sheppard, P.M. Elliott, D.J. Pennell, and S.K. Prasad Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
31. O. Bruder, A. Wagner, C.J. Jensen, S. Schneider, P. Ong, E.M. Kispert, K. Nassenstein, T. Schlosser, G.V. Sabin, U. Sechtem, and H. Mahrholdt Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
32. J.J. Green, J.S. Berger, C.M. Kramer, and M. Salerno Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy JACC Cardiovasc Imaging 5 2012 370 377
33. I. Olivotto, B.J. Maron, E. Appelbaum, C.J. Harrigan, C. Salton, C.M. Gibson, J.E. Udelson, C. O'Donnell, J.R. Lesser, W.J. Manning, and M.S. Maron Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy Am J Cardiol 106 2010 261 267
34. P. Spirito, C. Autore, F. Formisano, G.E. Assenza, E. Biagini, T.S. Haas, S. Bongioanni, C. Semsarian, E. Devoto, B. Musumeci, F. Lai, L. Yeates, M.R. Conte, C. Rapezzi, L. Boni, and B.J. Maron Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors Am J Cardiol 113 2014 1550 1555
35. M.S. Maron, J.J. Finley, J.M. Bos, R.H. Hauser, W.J. Manning, T.S. Haas, J.R. Lesser, J.E. Udelson, M.J. Ackerman, and B.J. Maron Prevalence, clinical significance and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy Circulation 118 2008 1541 1549
36. K.M. Harris, P. Spirito, M.S. Maron, A.G. Zenovich, F. Formisano, J.R. Lesser, S. Mackey-Bojack, W.J. Manning, J.E. Udelson, and B.J. Maron Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 2006 216 225
37. P. Sorajja, S.R. Ommen, R.A. Nishimura, B.J. Gersh, P.B. Berger, and A.J. Tajik Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease Circulation 108 2003 2342 2348
38. M.S. Maron, I. Olivotto, S. Betocchi, S.A. Casey, J.R. Lesser, M.A. Losi, F. Cecchi, and B.J. Maron Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303
39. G.K. Efthimiadis, D.G. Parcharidou, G. Giannakoulas, E.D. Pagourelias, P. Charalampidis, G. Savvopoulos, A. Ziakas, H. Karvounis, I.H. Styliadis, and G.E. Parcharidis Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy Am J Cardiol 104 2009 695 699
40. B.J. Maron, T.S. Haas, M.S. Maron, J.R. Lesser, J.A. Browning, R.H. Chan, I. Olivotto, R.F. Garberich, and R.S. Schwartz Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance Am J Cardiol 113 2014 1394 1400
41. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, M. Domanski, C. Troutman, J. Anderson, G. Johnson, S.E. McNulty, N. Clapp-Channing, L.D. Davidson-Ray, E.S. Fraulo, D.P. Fishbein, R.M. Luceri, J.H. Ip Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
42. A.J. Moss, W.J. Hall, D.S. Cannom, J.P. Daubert, S.L. Higgins, H. Klein, J.H. Levine, S. Saksena, A.L. Waldo, D. Wilber, M.W. Brown, and M. Heo Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 1996 1933 1940
43. C. O'Mahony, P.D. Lambiase, G. Quarta, M. Cardona, M. Calcagnino, K. Tsovolas, S. Al-Shaikh, S.M. Rahman, S. Arnous, S. Jones, W. McKenna, and P. Elliott The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy Heart 98 2012 116 125